ARCHIVES

Dendreon’s Provenge Approved For Prostate Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations.

April 28, 2006

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013